Jiang et al. suggested that knockdown of GRP78 can enhance the sensitivity of melanoma to chemotherapy drugs [27]; removing the tumor protection provided by ERS may enhance the sensitivity of chemotherapy drugs [28]. The gene discussed is HSPA5; the disease is neoplasm.